Recurrent Ovarian Carcinoma Suspended Phase 1 / 2 Trials for Carboxymethylcellulose (DB11059)

IndicationStatusPhase
DBCOND0030000 (Recurrent Ovarian Carcinoma)Suspended1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03206047Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment